Neomycin PCD Pharma Franchise Company
Cafoli Lifecare offers 12 Neomycin formulations across cream, ointment, eye drops and eye ointment, largely as combination products for the derma and ophthalmic segments. All are manufactured at WHO-GMP certified facilities with monopoly rights for partners.
What is Neomycin?
Neomycin is an aminoglycoside antibiotic. It binds to the bacterial 30S ribosomal subunit, causing misreading of mRNA and inhibiting protein synthesis, and is active against many Gram-negative and some Gram-positive organisms. Because of systemic toxicity it is used topically rather than by injection. See MedlinePlus.
Therapeutic Applications
Topical Neomycin is used for infected wounds, burns, infected dermatoses and post-operative skin care, usually combined with a corticosteroid or another antibiotic. Ophthalmic presentations are used for bacterial conjunctivitis and blepharitis. Prescribers include dermatologists, general physicians, surgeons and ophthalmologists.
Why Neomycin is a High-Potential Molecule for Distributors
Neomycin is a combination workhorse rather than a standalone star: it appears in steroid-antibiotic creams, antibiotic-antifungal ointments and ophthalmic combinations, so a single molecule underpins a dozen fast-moving SKUs. That spreads risk across many products and keeps stock turning even when any one brand slows.
Why Choose Cafoli Lifecare
Cafoli offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, attractive net rates and complete promotional inputs, with 1000+ franchise partners across India.
References
- MedlinePlus: Neomycin
- PubChem: Neomycin
Our formulations of Neomycin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: